<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <title>ArtAI: Neurology
 Week 5</title>
<link rel="stylesheet" type="text/css" href="../style.css">
</head>
<body>
	<nav>
	<a href="../index.html">Learn index.</a>
	<a href="index.html">Neurology index.</a>
	<a href="week1.html">Week 1.</a>
	<a href="week2.html">Week 2.</a>
	<a href="week3.html">Week 3.</a>
	<a href="week4.html">Week 4.</a>
	<a href="week5.html">Week 5.</a>
	<a href="week6.html">Week 6.</a>
	<a href="week7.html">Week 7.</a>
	<a href="exam.html">Exam.</a>
	</nav>

<h1>Week 5</h1>
<p><h2>Important concepts</h2></p>
<p><h3>1. GABAergic inhibition</h3></p>
<p><ul><li>GABA: Neurotransmitter gamma-Aminobutyric acid
</li>
<li>
Inhibition: Decrease in activity
</li>
<li>
Enzymatic step: Transformation of a molecule through another molecule.
</li>
<li>
Cytosol: Internal cell fluid.
</li>
</ul></p>
<p><h3>2. Inhibitory synaptic conductances</h3></p>
<p><ul><li>Shunting: Directing flow.
</li>
</ul></p>
<p><h3>3. Benzodiazepines</h3></p>
<p><ul><li>Compound: Assembly of proteins.
</li>
<li>
Antagonist: Receptor blocker.
</li>
</ul></p>
<p><h3>4. GABAergic projections</h3></p>
<p><ul><li>Thalamus: Connective brain centra.
</li>
</ul></p>
<p><h3>5. Neocortical inhibition</h3></p>
<p><ul><li>Volume transmission: Diffusion through extracellular fluid.
</li>
</ul></p>
<p><h2>Resources</h2></p>
<p><h3>Plain text</h3></p>
<p><ul><li><a href="http://artai.co/learn/neurology/5.1.txt">http://artai.co/learn/neurology/5.1.txt</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.2.txt">http://artai.co/learn/neurology/5.2.txt</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.3.txt">http://artai.co/learn/neurology/5.3.txt</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.4.txt">http://artai.co/learn/neurology/5.4.txt</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.5.txt">http://artai.co/learn/neurology/5.5.txt</a>
</li>
</ul></p>
<p><h3>PDF</h3></p>
<p><ul><li><a href="http://artai.co/learn/neurology/5.1.pdf"> 5.1 (2 MB)</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.2.pdf"> 5.2 (1 MB)</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.3.pdf"> 5.3 (2 MB)</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.4.pdf"> 5.4 (6 MB)</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.5.pdf"> 5.5 (2 MB)</a>
</li>
</ul></p>
<p><h3>Videos</h3></p>
<p><ul><li><a href="http://artai.co/learn/neurology/5.1-MwicvgOIsOY.3gp"> 5.1 (11 MB)</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.2-dmrrGkfcfNw.3gp"> 5.2 (9 MB)</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.3-oeLbdmx1AbE.3gp"> 5.3 (6 MB)</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.4-6ANiSN3Mpx4.3gp"> 5.4 (9 MB)</a>
</li>
<li>
<a href="http://artai.co/learn/neurology/5.5-QFKfZNXrX3w.3gp"> 5.5 (8 MB)</a>
</li>
</ul></p>
<p><h2>Questions</h2></p>
<p><h3>Question 5.1.1 </h3></p>
<p>Which of the following statements about the neurotransmitter GABA is correct?
<ul><li>GABA is synthesized in a single enzymatic step, in which the GAD enzyme produces GABA from acetylcholine
</li>
<li>
GABA is packaged into synaptic vesicles through the VGAT transporter 
</li>
<li>
The concentration of GABA inside a synaptic vesicle is about 100 nM
</li>
<li>
GABA is the main inhibitory neurotransmitter in the spinal cord, but not in the brain
</li>
</ul></p>
<p><h3>Question 5.1.2 </h3></p>
<p>Which of the following statements is not correct:
<ul><li>GABAergic neurons make synapses at specific dendritic locations
</li>
<li>
GABA acts upon postsynaptic neurons to prevent them from firing action potentials
</li>
<li>
GABAergic inhibition counteracts glutamatergic excitation in neuronal networks of the brain
</li>
<li>
Most neurons in the brain are GABAergic in order to maintain the balance between excitation and inhibiton 
</li>
</ul></p>
<p><h3>Question 5.1.3 </h3></p>
<p>There are two major classes of GABA receptors, GABA-A receptors and GABA-B receptors. How do these two classes of GABA receptors inhibit neuronal activity?
<ul><li>GABA-A receptors selectively conduct K+, and GABA-B receptors activate selective Cl- conductances via G-proteins
</li>
<li>
GABA-A and GABA-B receptors both conduct Cl- and K+
</li>
<li>
GABA-A receptors selectively conduct Na+, and GABA-B receptors selectively conduct Cl-
</li>
<li>
GABA-A receptors selectively conduct Cl-, and GABA-B receptors activate selective K+ conducances via G-proteins 
</li>
</ul></p>
<p><h3>Question 5.1.4 </h3></p>
<p>Which of the following statements about Cl- concentration is not correct:
<ul><li>The concentration of Cl- in the cytosol of a mature neuron is about 50 mM 
</li>
<li>
The concentration of Cl- in the extracellular space is about 120 mM
</li>
<li>
The KCC2 transporter is important for maintaining chloride concentrations within the neuron low
</li>
<li>
In early development, chloride concentration is high (~30 mM) in the cytosol of a neuron
</li>
</ul></p>
<p><h3>Question 5.1.5 </h3></p>
<p>GABA-A mediated postsynaptic conductances:
<ul><li>have approximately the same time course as GABA-B mediated postsynaptic conductances
</li>
<li>
are faster in onset and shorter in duration than GABA-B mediated postsynaptic conductances 
</li>
<li>
are faster in onset and longer in duration than GABA-B mediated postsynaptic conductances
</li>
<li>
are slower in onset and longer in duration than GABA-B mediated postsynaptic conductances
</li>
</ul></p>
<p><h3>Question 5.2.1 </h3></p>
<p>The reversal potential of the GABA-A receptor Cl- conductance is typically about:
<ul><li>0 mV
</li>
<li>
-35 mV
</li>
<li>
-55 mV
</li>
<li>
-75 mV 
</li>
</ul></p>
<p><h3>Question 5.2.2 </h3></p>
<p>Which of the following statements about the time course of inhibitory conductances mediated by GABA-A receptors is correct?
<ul><li>GABA-A inhibition is fast, and short lasting compared AMPA-mediated excitation 
</li>
<li>
GABA-A inhibition is fast, but itâ€™s much slower than AMPA-mediated excitation
</li>
<li>
GABA-A inhibition has almost the same duration as AMPA-mediated excitation
</li>
<li>
GABAergic inhibition is a slow process, but it's much faster than AMPA-mediated excitation
</li>
</ul></p>
<p><h3>Question 5.2.3 </h3></p>
<p>Which of the following statements regarding IPSPs and/or IPSCs is not correct?
<ul><li>The time course of the synaptic current is the same as the time course of the synaptic conductance 
</li>
<li>
IPSPs have longer durations that IPSCs
</li>
<li>
If the membrane potential is at the chloride reversal potential, then there is no GABA-A-mediated synaptic conductance
</li>
<li>
An IPSC typically lasts ~10 ms
</li>
</ul></p>
<p><h3>Question 5.2.4 </h3></p>
<p>Which of the following statements regarding hyperpolarising inhibition is correct?
<ul><li>GABA-A synaptic input causes hyperpolarising inhibition when the membrane potential is depolarised relative to the Cl- reversal potential 
</li>
<li>
GABA-A synaptic input causes hyperpolarising inhibition when the membrane potential is hyperpolarized relative to the Cl- reversal potential
</li>
<li>
GABA-A synaptic input causes hyperpolarising inhibition when the membrane potential is at the Cl- reversal potential
</li>
<li>
GABA-B synaptic input causes hyperpolarising inhibition when the membrane potential is hyperpolarised relative to the K+ reversal potential
</li>
</ul></p>
<p><h3>Question 5.2.5 </h3></p>
<p>Which of the following statements regarding shunting inhibition is correct?
<ul><li>GABA-A synaptic input causes shunting inhibition due to increased input resistance of the soma 
</li>
<li>
GABA-A synaptic input causes shunting inhibition due to increased membrane time constant
</li>
<li>
GABA-A synaptic input causes shunting inhibition due to increased axial resistance
</li>
<li>
GABA-A synaptic input causes shunting inhibition due to decreased membrane resistance
</li>
</ul></p>
<p><h3>Question 5.3.1 </h3></p>
<p>Which of the following compounds is not a GABA receptor blocker?
<ul><li>picrotoxin
</li>
<li>
bicuculline
</li>
<li>
gabazine
</li>
<li>
CNQX 
</li>
</ul></p>
<p><h3>Question 5.3.2 </h3></p>
<p>Which of the following statements about the action of benzodiazepines is correct?
<ul><li>Benzodiazepines act upon all GABA-A receptors
</li>
<li>
Benzodiazepines act upon all GABA-B receptors
</li>
<li>
Benzodiazepines act upon specific subtypes of GABA-A receptors 
</li>
<li>
Benzodiazepines act upon specific subtypes of GABA-B receptors
</li>
</ul></p>
<p><h3>Question 5.3.3 </h3></p>
<p>Which of the following statements about the mechanism of action of benzodiazepines is not correct?
<ul><li>Benzodiazepines do not activate GABA-A receptors by themselves, but they only potentiate GABA-evoked currents
</li>
<li>
Benzodiazepines increase the affinity of GABA to GABA-A receptor
</li>
<li>
Benzodiazepines are GABA-A receptor antagonists 
</li>
<li>
Benzodiazepines act on GABA-A receptors containing the a1, a2, a3 or a5 subunits, but not the a4 and a6 subunits
</li>
</ul></p>
<p><h3>Question 5.3.4 </h3></p>
<p>How do benzodiazepines affect mouse behaviour?
<ul><li>Benzodiazepines induce a sedative effect (sleep) and an anxiolytic effect (anti-anxiety) by acting on the same types of GABA-A receptors
</li>
<li>
Benzodiazepines induce an anxiolytic effect, which is largely mediated by GABA-B receptors
</li>
<li>
Benzodiazepines induce a sedative effect (sleep), which is largely mediated by GABA-A-a1 receptors 
</li>
<li>
Benzodiazepines induce an anxiogenic effect (increased anxiety), which is mediated by GABA-A-a2 receptors
</li>
</ul></p>
<p><h3>Question 5.3.5 </h3></p>
<p>Why might someone be prescribed benzodiazepenes by their doctor?
<ul><li>To reduce anxiety
</li>
<li>
To promote sleep or sedation
</li>
<li>
As an anticonvulsant to prevent epileptic seizures
</li>
<li>
All of the above are valid 
</li>
</ul></p>
<p><h3>Question 5.4.1 </h3></p>
<p>What neuronal circuit mediates feedback inhibition in the thalamus?
<ul><li>Inhibitory thalamic projection neurons inhibit excitatory nucleus reticularis (NRT) neurons 
</li>
<li>
Cortical glutamatergic excitation drives neurons in NRT, which innervate the principal thalamic nuclei
</li>
<li>
Glutamatergic thalamic projection neurons excite GABAergic NRT neurons which inhibit the thalamic projection neurons
</li>
<li>
Striatal GABAergic neurons reciprocally innervate the main thalamic nuclei
</li>
</ul></p>
<p><h3>Question 5.4.2 </h3></p>
<p>Why might feedback inhibition be useful to the brain ?
<ul><li>Feedback inhibition prevents run-away excitation
</li>
<li>
Feedback inhibition can help select the most important strong excitatory inputs, while filtering out smaller signals
</li>
<li>
Feedback inhibition can help sharpen spatiotemporal receptive fields
</li>
<li>
All of the above 
</li>
</ul></p>
<p><h3>Question 5.4.3 </h3></p>
<p>Where do GABAergic striatal projection neurons innervate?
<ul><li>Cerebellum
</li>
<li>
Substantia nigra (SNr) 
</li>
<li>
Olfactory bulb
</li>
<li>
Barrel cortex
</li>
</ul></p>
<p><h3>Question 5.4.4 </h3></p>
<p>Which statement about dopamine is not correct?
<ul><li>Dopaminergic innervation of striatum is prominent
</li>
<li>
Symptoms of Parkinson's disease likely result importantly from degeneration of dopamine neurons
</li>
<li>
Dopamine acts on D1 and D2 receptors expressed on different cell-types in the striatum
</li>
<li>
Dopamine acts on ionotropic dopamine receptors in the striatum 
</li>
</ul></p>
<p><h3>Question 5.4.5 </h3></p>
<p>What are the output neurons of the cerebellar cortex and which neurotransmitter do they release?
<ul><li>Pyramidal neurons / Glutamate
</li>
<li>
Pyramidal neurons / GABA
</li>
<li>
Purkinje cells / Glutamate
</li>
<li>
Purkinje cells / GABA 
</li>
</ul></p>
<p><h3>Question 5.5.1 </h3></p>
<p>Which statement about neocortical GABAergic neurons is incorrect?
<ul><li>Neocortical GABAergic neurons prominently inhibit sub-cortical nuclei 
</li>
<li>
Some subtypes of neocortical GABAergic neurons inhibit other neocortical GABAergic neurons
</li>
<li>
Neocortical GABAergic neurons represent about 10-20% of the total number of cortical neurons
</li>
<li>
Most neocortical GABAergic neurons are local interneurons and don't have long-range axonal projections
</li>
</ul></p>
<p><h3>Question 5.5.2 </h3></p>
<p>Which one below is not a neocortical GABAergic neuron?
<ul><li>Parvalbumin-expressing (PV)
</li>
<li>
Somatostatin-expressing (Sst)
</li>
<li>
Vasoactive intestinal peptide-expressing (VIP)
</li>
<li>
Purkinje cells 
</li>
</ul></p>
<p><h3>Question 5.5.3 </h3></p>
<p>Parvalbumin-expressing (PV) basket cells innervate which part of postsynaptic target neurons?
<ul><li>Distal dendrites
</li>
<li>
Soma and proximal dendrites 
</li>
<li>
Gap junctions
</li>
<li>
Axon initial segment
</li>
</ul></p>
<p><h3>Question 5.5.4 </h3></p>
<p>Where do neocortical somatostatin-expressing GABAergic neurons (Sst) prominently innervate excitatory pyramidal neurons?
<ul><li>Distal dendrites 
</li>
<li>
Basal dendrites
</li>
<li>
Nodes of Ranvier
</li>
<li>
Soma
</li>
</ul></p>
<p><h3>Question 5.5.5 </h3></p>

Which neocortical GABAergic neuron sub-type is thought to signal mainly by volume transmisson?
<ul><li>Somatostatin-expressing GABAergic neurons (Sst)
</li>
<li>
Parvalbumin-expressing GABAergic neurons (PV)
</li>
<li>
Neurogliaform GABAergic neurons 
</li>
<li>
Vasoactive intestinal peptide-expressing GABAergic neurons (VIP)
</li>
</ul>


</body>
</html>